But yes, with the growth of 7% in the quarter, we now have rolling 12-month revenues of 7.2 billion Swedish kronor and an adjusted EBIT margin for 2025 of 4.2%.
Let's take a closer look at the growth in the fourth quarter. The growth was of 7% in the quarter and was impacted by an internal focus during 2025, as mentioned. And that's related to launching the new fulfillment center in Varberg and also scaling up that, to the right you can see our gross margin development, and we had a lower gross margin in Q4 of 24.8%, and the gross margin was impacted by factors related to the fourth quarter, such as campaign sales and additional purchasing related costs.
This was partly affected by the ramp-up in Varberg.
And Q4 has always been an intense campaign period. With Black Friday, the intensity tends to increase year-over-year.
This year, we had more campaign sales and also a lower campaign-related margin, and we had additional purchasing-related costs related to Varberg.
An example of this is the calibration of purchases for our new logistics centers, which involves restocking products at a higher price from wholesalers and having products in stock that are later discounted, a situation often seen with some monthly specific assortments.
Profitability was down in Q4 compared to a year ago. As mentioned, adjusted EBIT margin of 1.3%, and it was impacted not only by the lower gross margin, but also increased depreciation. To the right. You can see our Operating Cost and D&A in percentage of revenue.
And as you can see, depreciation increased in percentage of sales by close to one percentage point in Q4. However, all other operating costs were down, and that was due to our ongoing efficiency work at Apotea related to logistics and elsewhere.